Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. PS Ratio 2006–2026
Current and historical P/S ratio for Regeneron Pharmaceuticals, Inc. (REGN): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 5.92.
From: 06/30/2010To: 03/31/2026
Stock Price
TTM Revenue
PS Ratio
Regeneron Pharmaceuticals Inc. PS Ratio — FAQ
Regeneron Pharmaceuticals Inc. (REGN) ps ratio over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's ps ratio history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s ps ratio by year and by quarter, including the growth rate.